Profile data is unavailable for this security.
About the company
PT Darya-Varia Laboratoria Tbk (Darya-Varia) is an Indonesia-based company operating in the pharmaceutical industry. Its segments include prescription drugs, consumer health products, and export and toll manufacturing services. The Company provides products and services for consumer health, skin nutrition, respiratory, vitamins and daily relief. The Company’s products include Remscar (silicone gel), Carvilol, Ondavar (antiemetic), Etorix, Forti-D (vitamin D supplement), Decolgen, Neozep, Stop Cold, Decolsin, and Allerin. The Carvilol is used for heart health and treating hypertension. Ondavar is an antiemetic product used for nausea and vomiting during pregnancy. Etorix is a pain reliever. Forti-D is a supplement to fulfill the body’s need for vitamin D3. Darya-Varia provides a range of brands such as Enervon-C, Enervon Active, and Supertin that helps to boost body immune and maintain health. The Company also provides Imunped as supplement for kids with Zinc and vitamin C for children.
- Revenue in IDR (TTM)1.86tn
- Net income in IDR43.95bn
- Incorporated1976
- Employees1.26k
- LocationDarya-Varia Laboratoria Tbk PTLantai 8-10, Talavera Office ParkJl. Letjen T.B. Simatupang Kav. 22-26JAKARTA 12430IndonesiaIDN
- Phone+62 2 122768000
- Fax+62 2 122768016
- Websitehttp://www.darya-varia.com
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Phapros Tbk PT | 1.17tn | 28.07bn | 575.40bn | 1.51k | 20.50 | 0.7661 | 7.14 | 0.4924 | 33.42 | 33.42 | 1,391.04 | 894.11 | 0.6412 | 1.87 | 2.63 | 772,289,800.00 | 1.50 | 3.51 | 2.54 | 6.82 | 49.99 | 52.91 | 2.34 | 6.06 | 0.9357 | 1.59 | 0.5222 | -- | 11.13 | 3.12 | 153.55 | -25.86 | -29.64 | -- |
| Merck Tbk PT | 1.15tn | 163.62bn | 2.15tn | 393.00 | 13.17 | 2.97 | 11.34 | 1.88 | 365.22 | 365.22 | 2,561.49 | 1,621.14 | 1.22 | 2.16 | 8.41 | 2,980,644,000.00 | 17.45 | 7.22 | 21.69 | 10.91 | 37.78 | 39.04 | 14.26 | 9.53 | 1.92 | 34.45 | 0.0235 | 426.22 | 62.29 | 0.5654 | 83.11 | -3.07 | 11.07 | -2.69 |
| Indofarma Tbk PT | 2.31tn | -223.52bn | 2.18tn | 1.18k | -- | 6.72 | -- | 0.9463 | -72.15 | -72.15 | 745.51 | 104.92 | 1.11 | 6.05 | 5.69 | 1,842,803,000.00 | -10.77 | -1.40 | -23.64 | -2.79 | 1.35 | 17.81 | -9.68 | -1.18 | 0.9242 | -3.14 | 0.5993 | -- | 69.15 | 11.62 | -136,356.00 | -- | -18.53 | -- |
| Darya-Varia Laboratoria Tbk PT | 1.86tn | 43.95bn | 2.21tn | 1.26k | 50.32 | 1.52 | 20.61 | 1.19 | 39.25 | 39.25 | 1,657.99 | 1,300.03 | 0.8719 | 2.22 | 2.66 | 1,498,745,000.00 | 2.06 | 9.98 | 2.72 | 13.52 | 52.33 | 53.53 | 2.37 | 10.13 | 2.18 | -- | 0.0018 | 67.95 | 3.89 | 5.54 | -9.47 | -0.7147 | -14.99 | 11.89 |
| Kimia Farma Tbk PT | 10.50tn | -180.60bn | 5.17tn | 11.51k | -- | 0.7165 | 19.74 | 0.4928 | -32.52 | -32.52 | 1,890.12 | 1,297.92 | 0.5598 | 2.19 | 4.54 | 881,718,000.00 | -1.01 | 1.82 | -1.64 | 3.00 | 33.85 | 36.28 | -1.80 | 2.55 | 0.5965 | 0.5404 | 0.5492 | 24.79 | 28.50 | 17.21 | 1,613.68 | 2.48 | 12.14 | 11.14 |
| Tempo Scan Pacific Tbk PT | 11.98tn | 818.70bn | 6.29tn | 4.55k | 7.62 | 0.9196 | 5.51 | 0.5252 | 183.00 | 183.00 | 2,679.31 | 1,516.93 | 1.18 | 4.34 | 9.26 | 2,535,298,000.00 | 8.48 | 8.33 | 11.51 | 11.46 | 34.26 | 37.20 | 7.16 | 6.44 | 1.85 | -- | 0.1604 | 36.32 | 2.43 | 4.22 | 4.57 | 8.96 | -0.1237 | 6.96 |
| Soho Global Health Tbk PT | 6.89tn | 325.04bn | 6.60tn | 2.41k | 20.30 | 2.65 | 16.78 | 0.9574 | 256.10 | 256.10 | 5,431.66 | 1,963.83 | 1.52 | 4.70 | 4.87 | 2,875,966,000.00 | 7.15 | -- | 12.94 | -- | 18.72 | -- | 4.72 | -- | 1.46 | -- | 0.0108 | -- | 14.80 | -- | 219.67 | -- | -- | -- |
